Literature DB >> 30387168

Effects of ANRIL polymorphisms on the likelihood of coronary artery disease: A meta-analysis.

Yingli Xie1, Di Zhao1, Pingshuan Dong1, Honglei Wang1, Daolin Li1, Lihong Lai1.   

Abstract

BACKGROUND: Whether antisense noncoding RNA in the INK4 locus (ANRIL) polymorphisms are associated with the likelihood of coronary artery disease (CAD) remains controversial. Therefore, we performed this study to explore correlation between ANRIL polymorphisms and CAD.
METHODS: Literature retrieve was conducted in PubMed, Medline and Embase. Odds ratios and 95% confidence intervals were calculated.
RESULTS: Nineteen studies were enrolled for analyses. Pooled overall analyses showed that rs1333040 (dominant model: P < 0.0001; recessive model: P < 0.0001; allele model: P < 0.0001), rs1333049 (dominant model: P = 0.02; allele model: P = 0.02) and rs2383207 (additive model: P = 0.004; allele model: P = 0.03) polymorphisms were significantly associated with the likelihood of CAD. Further subgroup analyses revealed that rs1333040, rs1333049, rs2383206, rs2383207, rs10757274, and rs10757278 polymorphisms were all significantly correlated with the likelihood of CAD in East Asians. Additionally, rs2383206, rs10757274, and rs10757278 polymorphisms were also significantly correlated with the likelihood of CAD in Caucasians and West Asians.
CONCLUSIONS: Our findings indicated that rs1333040, rs1333049, rs2383206, rs2383207, rs10757274, and rs10757278 polymorphisms may serve as genetic biomarkers of CAD in East Asians. Moreover, rs2383206, rs10757274, and rs10757278 polymorphisms may also serve as genetic biomarkers of CAD in Caucasians and West Asians.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  antisense noncoding RNA in the INK4 locus; coronary artery disease; gene polymorphisms; meta-analysis

Mesh:

Substances:

Year:  2018        PMID: 30387168     DOI: 10.1002/jcb.27898

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Genetic association of ANRIL with susceptibility to Ischemic stroke: A comprehensive meta-analysis.

Authors:  Na Bai; Wei Liu; Tao Xiang; Qiang Zhou; Jun Pu; Jing Zhao; Danyang Luo; Xindong Liu; Hua Liu
Journal:  PLoS One       Date:  2022-06-02       Impact factor: 3.752

Review 2.  The Long Non-Coding RNA Landscape of Atherosclerotic Plaques.

Authors:  Weronika Kraczkowska; Paweł Piotr Jagodziński
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

3.  Long Non-coding RNAs Genes Polymorphisms and Their Expression Levels in Patients With Rheumatoid Arthritis.

Authors:  Tian-Ping Zhang; Bang-Qiang Zhu; Sha-Sha Tao; Yin-Guang Fan; Xiao-Mei Li; Hai-Feng Pan; Dong-Qing Ye
Journal:  Front Immunol       Date:  2019-10-31       Impact factor: 7.561

4.  Genetic and epigenetic associations of ANRIL with coronary artery disease and risk factors.

Authors:  Bayi Xu; Zhixia Xu; Yequn Chen; Nan Lu; Zhouwu Shu; Xuerui Tan
Journal:  BMC Med Genomics       Date:  2021-10-06       Impact factor: 3.063

Review 5.  Long Non-Coding RNA Regulation of Epigenetics in Vascular Cells.

Authors:  Hester Garratt; Robert Ashburn; Miron Sopić; Antonella Nogara; Andrea Caporali; Tijana Mitić
Journal:  Noncoding RNA       Date:  2021-09-23

6.  New findings in the roles of Cyclin-dependent Kinase inhibitors 2B Antisense RNA 1 (CDKN2B-AS1) rs1333049 G/C and rs4977574 A/G variants on the risk to coronary heart disease.

Authors:  Wei Yuan; Wei Zhang; Wei Zhang; Zhong-Bao Ruan; Li Zhu; Yu Liu; Yuan-Yuan Mi; Li-Feng Zhang
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.